 |
The
patient-perceived difficulty in diabetes treatment (PDDT) scale
identifies barriers to care |
| |
The PDDT scale is a simple and valid instrument
that may assist in identifying potential barriers in adherence
to recommended treatments and to new treatment options (Diabetes/Metabolism
Research and Reviews) |
| |
|
|
Care
Planning Improving the Lives of People with Long Term Conditions |
| |
This document focuses on people who have long
term physical health problems and describes how GPs and the other
member of the primary health care team can support them to live
their lives more comfortably with their condition (Clinical Innovation & Research Centre - Royal College of General Practitioners, UK) |
| |
|
|
Greater
management of hyperglycaemia in patients with acute coronary
syndromes needed |
| |
Patients with acute coronary syndromes (ACS)
should have their blood glucose levels actively controlled if it
is raised on admission to hospital, says NICE |
| |
|
|
Effective
Use of Structured Self-Management of Blood Glucose in Type 2
Diabetes: Lessons From the STeP Study |
| |
Although some studies have questioned the value
and utility of SMBG, specifically in non–insulin-treated patients, more recent studies have shown that appropriate use
of structured SMBG, within the framework of a collaborative relationship
between patients and their clinicians, facilitates and reinforces
adoption of healthy behaviors and promotes timely and persistent
therapy adjustments, resulting in improved clinical and behavioral
outcomes (Clinical Diabetes) |
| |
|
|
Diagnosis
and management of maturity onset diabetes of the young (MODY) |
| |
In this review we discuss when the general physician
might suspect MODY and how to identify which patients with diabetes
should be offered genetic testing - Clinical review (BMJ) |
| |
|
|
Artificial
Pancreas Breakthrough |
| |
For the first time in the world, the Artificial
Pancreas - aimed to provide a real solution for diabetics - was
tested successfully outside the confines of the hospital (Schneider
Children’s Medical Center, Israel) |
| |
|
|
A
five-year prospective study of bone mineral density in men and
women with diabetes: The Fremantle Diabetes Study |
| |
Changes in biochemical markers suggest that,
in type 1 men, there is ineffective bone formation associated with
accelerated bone resorption and lower sex steroid bioavailability.
These findings may have implications for the clinical management
of young male adults with diabetes (Acta Diabetologica) |
| |
|
|
Use
of Diffusion Tensor MRI to Identify Early Changes in Diabetic
Nephropathy |
| |
This pilot study suggests that changes in medullary
DTI assessments may serve as indicators of early DN (American Journal
of Nephrology) |
| |
|
|
Gut
microbiota and diabetes: from pathogenesis to therapeutic perspective |
| |
The last 5 years have demonstrated that intestinal
microbiota, at its molecular level, is a causal factor early in
the development of the diseases. Nonetheless, much more need to
be uncovered in order to identify first, new predictive biomarkers
so that preventive strategies based on pre- and probiotics, and
second, new therapeutic strategies against the cause rather than
the consequence of hyperglycemia and body weight gain (Acta Diabetologica) |
| |
|
|
Increased
Plasma Levels of Nesfatin-1 in Patients with Newly Diagnosed
Type 2 Diabetes Mellitus |
| |
Plasma nesfatin-1 concentrations were found
to be elevated in subjects with both IGT and nT2DM and to be related
with several clinical parameters known to be associated with insulin
resistance (Experimental and Clinical Endocrinology & Diabetes) |
| |
|
|
Diagnosis
and Treatment of Diabetic Patients Requiring Insulin Who Repeatedly
Manifest Hyperglycemia and Hypoglycemia Due to Anti-Insulin Antibodies |
| |
Cyclophosphamide pulse therapy(CPT) combined
with prednisolone therapy seems to be the most effective treatment
to control the hyperglycemia and hypoglycemia associated with the
presence of IAs in diabetic patients treated with insulin (Clinical
Diabetes) |
| |
|
|
New
International Association of the Diabetes and Pregnancy Study
Groups (IADPSG) recommendations for diagnosing gestational diabetes
compared with former criteria: a retrospective study on pregnancy
outcome |
| |
The new criteria for diagnosing gestational
diabetes identified a group of women previously classifiable as
normal according to the 4th International Workshop Conference criteria,
but revealing metabolic characteristics and pregnancy outcomes
resembling those of women who would have been considered to have
gestational diabetes by the previous criteria (Diabetic Medicine) |
| |
|
|
European
Medicines Agency clarifies opinion on pioglitazone and the risk
of bladder cancer |
| |
Positive benefit-risk balance confirmed as second
and third line treatment (European Medicines Agency) |
| |
|
